Brief: Revive Therapeutics To Pursue The Psychedelic Market With Agreement And Investment In Red Light Holland Financing
10/02/2020 12:06
Feb 10 (Reuters) - Revive Therapeutics Ltd RVV.CD :
* REVIVE THERAPEUTICS TO PURSUE THE PSYCHEDELIC MARKET WITH
AGREEMENT AND INVESTMENT IN RED LIGHT HOLLAND FINANCING
Source text for Eikon: ID:nGNX6vyGHs
Further company coverage: RVV.CD
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Revive Therapeutics
See all newsBrief: Revive Therapeutics Provides Update Of Key Nerve Agent Countermeasure Study
Brief: Revive Therapeutics Provides Update Of Key Nerve Agent Countermeasure Study
Brief: Revive Therapeutics Announces Closing Of Second Tranche Of Private Placement
Brief: Revive Therapeutics Nears Completion Of Key Nerve Agent Countermeasure Study With Canadian Department Of National Defence
Brief: Revive Therapeutics Provides Update On Research Study Evaluating Bucillamine For Nerve Agent Exposure